Precision Optics (NASDAQ:POCI – Get Free Report) is one of 511 publicly-traded companies in the “Healthcare Equipment & Supplies” industry, but how does it weigh in compared to its peers? We will compare Precision Optics to related businesses based on the strength of its dividends, valuation, institutional ownership, analyst recommendations, profitability, risk and earnings.
Risk & Volatility
Precision Optics has a beta of 0.23, meaning that its share price is 77% less volatile than the S&P 500. Comparatively, Precision Optics’ peers have a beta of 2.57, meaning that their average share price is 157% more volatile than the S&P 500.
Earnings and Valuation
This table compares Precision Optics and its peers revenue, earnings per share and valuation.
| Gross Revenue | Net Income | Price/Earnings Ratio | |
| Precision Optics | $31.53 million | -$3.63 million | -11.11 |
| Precision Optics Competitors | $1.89 billion | $135.83 million | 12.13 |
Precision Optics’ peers have higher revenue and earnings than Precision Optics. Precision Optics is trading at a lower price-to-earnings ratio than its peers, indicating that it is currently more affordable than other companies in its industry.
Analyst Recommendations
This is a summary of recent ratings and target prices for Precision Optics and its peers, as reported by MarketBeat.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Precision Optics | 1 | 0 | 0 | 0 | 1.00 |
| Precision Optics Competitors | 4281 | 10557 | 18338 | 829 | 2.46 |
As a group, “Healthcare Equipment & Supplies” companies have a potential upside of 19.88%. Given Precision Optics’ peers stronger consensus rating and higher possible upside, analysts clearly believe Precision Optics has less favorable growth aspects than its peers.
Institutional and Insider Ownership
13.7% of Precision Optics shares are owned by institutional investors. Comparatively, 40.5% of shares of all “Healthcare Equipment & Supplies” companies are owned by institutional investors. 14.4% of Precision Optics shares are owned by insiders. Comparatively, 14.9% of shares of all “Healthcare Equipment & Supplies” companies are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.
Profitability
This table compares Precision Optics and its peers’ net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Precision Optics | -11.51% | -23.92% | -13.05% |
| Precision Optics Competitors | -304.51% | -178.77% | -22.17% |
Summary
Precision Optics peers beat Precision Optics on 10 of the 13 factors compared.
About Precision Optics
Precision Optics Corporation, Inc. designs, develops, manufactures, and sells specialized optical and illumination systems and related components primarily in the United States and the European Economic Area. It offers medical instrumentation products, including endoscopes and endocouplers, as well as other custom imaging and illumination products, such as Microprecision lenses and micro medical cameras, and 3D endoscopes for use in minimally invasive surgical procedures by hospitals and physicians. The company also provides components and assemblies for industrial and military use. It markets its products to medical device companies. The company was incorporated in 1982 and is based in Gardner, Massachusetts.
Receive News & Ratings for Precision Optics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Precision Optics and related companies with MarketBeat.com's FREE daily email newsletter.
